RESUMEN
OBJECTIVE:To investigate the clinical efficacy and bacteriological efficacy of biapenem in the treatment of acute bacterial infection,and its effects on serum IL-6 and hs-CRP levels. METHODS:A total of 241 patients with acute bacterial infec-tion of respiratory system and urinary tract system selected from our hospital during Apr. 2015-Apr. 2016 were divided into control group(119 cases)and observation group(122 cases)according to random number table. Control group was given Meropenem for injection 0.5 g added into 100 mL 0.9% NaCl injection intravenously,tid. Observation group was given Biapenem for injection 0.3 g added into 100 mL 0.9% NaCl injection intravenously,bid. Treatment course of 2 groups lasted for 7-14 d. Clinical effica-cies,bacteriological efficacies,serum interleukin-6(IL-6)and hypersensitive C-reactive protein(hs-CRP)levels,the occurrence of ADR were compared between 2 groups. RESULTS:The total response rate,bacterial culture positive rate,bacterial clearance rate and the incidence of ADR were 88.24%,56.30%,87.14%,13.45% in control group and 93.44%,55.74%,93.06%,10.66% in observation group,without statistical significance(P>0.05). Before treatment,there was no statistical significance in serum IL-6 or hs-CRP levels between 2 groups(P>0.05). Compared with before treatment,serum IL-6 and hs-CRP levels of 2 groups were decreased significantly after treatment,with statistical significance(P<0.05);there was no statistical significance between 2 groups(P>0.05). CONCLUSIONS:Biapenem in the treatment of acute bacterial infection of respiratory system and urinary tract system has excellent efficacy,and can significantly reduce inflammatory factor level with good safety. Response rate and safety of biapenem are similar to those of meropenem,so drugs should be selected according to specific condition of patients.
RESUMEN
OBJECTIVE:To investigate the clinical efficacy and bacteriological efficacy of biapenem in the treatment of acute bacterial infection,and its effects on serum IL-6 and hs-CRP levels. METHODS:A total of 241 patients with acute bacterial infec-tion of respiratory system and urinary tract system selected from our hospital during Apr. 2015-Apr. 2016 were divided into control group(119 cases)and observation group(122 cases)according to random number table. Control group was given Meropenem for injection 0.5 g added into 100 mL 0.9% NaCl injection intravenously,tid. Observation group was given Biapenem for injection 0.3 g added into 100 mL 0.9% NaCl injection intravenously,bid. Treatment course of 2 groups lasted for 7-14 d. Clinical effica-cies,bacteriological efficacies,serum interleukin-6(IL-6)and hypersensitive C-reactive protein(hs-CRP)levels,the occurrence of ADR were compared between 2 groups. RESULTS:The total response rate,bacterial culture positive rate,bacterial clearance rate and the incidence of ADR were 88.24%,56.30%,87.14%,13.45% in control group and 93.44%,55.74%,93.06%,10.66% in observation group,without statistical significance(P>0.05). Before treatment,there was no statistical significance in serum IL-6 or hs-CRP levels between 2 groups(P>0.05). Compared with before treatment,serum IL-6 and hs-CRP levels of 2 groups were decreased significantly after treatment,with statistical significance(P<0.05);there was no statistical significance between 2 groups(P>0.05). CONCLUSIONS:Biapenem in the treatment of acute bacterial infection of respiratory system and urinary tract system has excellent efficacy,and can significantly reduce inflammatory factor level with good safety. Response rate and safety of biapenem are similar to those of meropenem,so drugs should be selected according to specific condition of patients.
RESUMEN
This case-control study aimed to clarify the short- and long-term outcomes of laparoscopic surgery for rectal cancer after neoadjuvant chemo radiotherapy compared with conventional open resection. Between January 2008 and December 2014, a series of 227 patients with rectal cancer underwent radical surgery after neoadjuvant chemo radiotherapy. Age, gender, American Society of Anesthesiologists score, clinical stage, and type of resection were matched by propensity scoring and 106 patients [53 patients with laparoscopic total mesorectal excision and 53 patients with open resection] were selected for analysis. There were no significant differences in the clinicopathological features between the two groups. With regard to short-term outcomes, blood loss, postoperative analgesia and hospital stay were significantly shorter in the laparoscopy group than in the open group, whereas operative time was significantly longer in the laparoscopy group than in the open group. The overall morbidity was similar in the two groups. There were no significant differences in the 5-year overall and disease-free survival rates between the two groups. In summary, laparoscopic surgery may be both feasible and efficient compared with open resection for rectal cancer after neoadjuvant chemo radiotherapy